Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,465Revenue (TTM) $M191Net Margin (%)-68.3Altman Z-Score-2.4
Enterprise Value $M2,439EPS (TTM) $-1.0Operating Margin %-40.2Piotroski F-Score2
P/E(ttm)--Beneish M-Score6.4Pre-tax Margin (%)-68.1Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio3.9Cash flow > EarningsY
Price/Sales12.75-y EBITDA Growth Rate %-19.4Current Ratio4.0Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %-237.1ROA % (ttm)-27.6Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-1,588.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M137ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with NKTR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NKTRJoel Greenblatt 2015-09-30 Sold Out -0.14%$9.5 - $13.92
($11.79)
$ 18.0353%Sold Out0
NKTRJoel Greenblatt 2015-06-30 Buy 0.14%$9.52 - $13.84
($11.47)
$ 18.0357%New holding1,363,927
NKTRFirst Eagle Investment 2011-12-31 Sold Out -0.003%$4.22 - $5.62
($4.92)
$ 18.03266%Sold Out0
NKTRFirst Eagle Investment 2011-09-30 Buy $4.98 - $7.65
($5.97)
$ 18.03202%New holding125,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NKTR is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


NKTR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KUEBLER CHRISTOPHER ADirector 2016-09-16Sell7,500$19.13-1.99view
Lingnau LutzDirector 2016-09-15Sell9,000$19.06-1.63view
CHESS ROBERTDirector 2016-09-15Sell12,000$19.21-2.39view
ROBIN HOWARD WPresident & CEO 2016-09-01Sell87,500$17.835.16view
Nicholson JohnSVP & COO 2016-08-16Sell3,317$17.566.78view
Thomsen Jillian B.SVP & Chief Accounting Officer 2016-08-16Sell3,971$17.566.78view
ROBIN HOWARD WPresident & CEO 2016-08-16Sell11,817$17.566.78view
Labrucherie Gil MSVP & CFO 2016-08-16Sell3,305$17.566.78view
Hora ManinderSVP Pharma Dev & Mfg Ops 2016-08-16Sell3,305$17.566.78view
Gergel Ivan P.SVP & Chief Medical Officer 2016-08-16Sell1,685$17.566.78view

Quarterly/Annual Reports about NKTR:

News about NKTR:

Articles On GuruFocus.com
Weekly CEO Sales Highlight: Monolithic Power Systems, Five Prime Therapeutics, Nektar Therapeutics Feb 15 2016 
Weekly CEO Sells Highlight: Cadence Design Systems Inc., Nektar Therapeutics Inc., Netflix Inc., Pho Sep 27 2015 
Weekly Guru Bargains Highlights: AKAM, NKTR, LOGI, FFIV, LCC Apr 16 2011 
Weekly Guru Bargains Highlights: AMSC, LOGI, NKTR, DAL, AIG Apr 09 2011 
Four Guru Stocks near New Lows: FBN, HOME, NKTR, PETS Feb 07 2011 
MannKind: Deja Vu for the FDA and Afrezza Dec 29 2010 
Nektar Therapeutics Reports Operating Results (10-Q) Nov 04 2010 
Nektar Therapeutics Reports Operating Results (10-Q) Jul 29 2010 
Nektar Therapeutics Reports Operating Results (10-Q) May 06 2010 
Small-Cap Biotech Stocks: Why This Sector Is Set for a Huge Year Jan 06 2010 

More From Other Websites
The opioids of the future won't get you high Sep 18 2016
4 stocks to watch Sep 14 2016
Two Californian research teams are on the path to ending the opioid crisis — and their drugs have... Sep 13 2016
Nektar And Three Other Momentum Stocks With Bullish Charts Sep 08 2016
[$$] Two Biotech CEOs Make $1M Stock Sales Sep 08 2016
4 stocks to watch Sep 07 2016
Mobileye And Three More Stocks Breaking Out Aug 24 2016
ETF’s with exposure to Nektar Therapeutics : August 22, 2016 Aug 22 2016
NEKTAR THERAPEUTICS Financials Aug 12 2016
ETF’s with exposure to Nektar Therapeutics : August 11, 2016 Aug 11 2016
Nektar Therapeutics :NKTR-US: Earnings Analysis: Q2, 2016 By the Numbers : August 8, 2016 Aug 08 2016
[$$] Nektar Therapeutics' Sweet Pipeline Aug 05 2016
NEKTAR THERAPEUTICS Files SEC form 10-Q, Quarterly Report Aug 04 2016
Don't Roll the Dice on Central Bank News Aug 04 2016
Edited Transcript of NKTR earnings conference call or presentation 3-Aug-16 9:00pm GMT Aug 03 2016
Nektar Therapeutics Earnings Call scheduled for 5:00 pm ET today Aug 03 2016
NEKTAR THERAPEUTICS Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 03 2016
Nektar reports 2Q loss Aug 03 2016
Nektar reports 2Q loss Aug 03 2016
Nektar Therapeutics Reports Financial Results for the Second Quarter of 2016 Aug 03 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)